https://www.denmarkherald.com/article/906350057-evaxion-s-ai-immunology-platform-demonstrates-86-vaccine-target-precision-in-phase-2-personalized-cancer-vaccine-trial The Denmark Herald en PressRelease 2026-04-17T19:10:00+00:00 Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.denmarkherald.com/article/906350035-new-data-demonstrates-the-unique-scalability-of-evaxion-s-ai-immunology-platform-in-glioblastoma The Denmark Herald en PressRelease 2026-04-17T19:00:00+00:00 New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.denmarkherald.com/article/906260754-new-nordic-white-paper-reveals-systemic-barriers-preventing-women-from-reaching-leadership-roles The Denmark Herald en PressRelease 2026-04-17T08:00:00+00:00 New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles https://ml-eu.globenewswire.com/media/67f65e0c-87c4-4f95-92fa-0b52d6248335/medium/women-in-life-science-denmark-white-paper.jpg